# No Impact Not No Progress An Evidence Led Bridge to Bone Loading When Jumping Is Not Tolerable

Research in postmenopausal women is unusually consistent on one point: the most reliable bone mineral density (BMD) gains come from **progressive heavy resistance training**, and outcomes often improve further when **impact** is added—done for months, not weeks. That lines up with what position statements say bone responds to: **specific mechanical loading**, not just “being active” (Kohrt et al., 2004; Watson et al., 2018).

The practical problem is that many people can’t tolerate impact right now because of pelvic floor symptom provocation, a joint flare, a bone stress history, or simply hard-earned caution after setbacks. If you’ve been told to “just do some gentle jumping” or, conversely, “never lift heavy,” it makes perfect sense that you feel stuck—those are not actionable training plans. That’s where the “impact-or-nothing” trap shows up: bone-focused training becomes either (1) a lot of effort that still **under-loads bone**, or (2) a rushed return to jumping that **outpaces tissue capacity** and triggers next-day consequences. This article is built for the middle ground: a **no-impact bridge** that still respects bone physics, so training can move forward without pretending that walking more is the same stimulus as high-strain loading.

Here’s what you’ll gain by reading on:

- A simple model for the **three adaptation lanes** that don’t progress on the same timeline: **bone stimulus**, **tendon/foot-ankle capacity**, and **optional future landing skill**.  
- How the two predictable mistakes happen—**under-dosing** and **too-early impact under fatigue**—and how to avoid them.  
- A practical framework of **four training dials** so you can adjust one variable at a time (instead of guessing): **magnitude**, **rate**, **distribution**, and **novelty**.  
- A weekly template (“the no-impact osteogenic stack”) plus a minimal tracking setup, including the **24-hour response check** as a guardrail for symptoms and recovery.

Throughout, the evidence boundaries stay explicit: if maximizing BMD is the goal and impact becomes tolerable, **heavy resistance training plus impact remains the most supported route** (Watson et al., 2018). This bridge isn’t a substitute for that—it’s a way to keep training moving while you build the capacity that makes future impact more predictable and less costly in symptoms.

## The “Impact-or-Nothing” Trap: Building a No-Impact Bridge That Still Respects Bone Physics

Research in postmenopausal women shows the most reliable BMD gains come from **high-load progressive resistance training**, often paired with **impact**, performed consistently for months (e.g., LIFTMOR used ~**80–85% 1RM** plus impact over ~8 months) (Watson et al., 2018). Position stands and reviews converge on the underlying principle: bone adapts to **specific mechanical loading**, not just “being active” (Kohrt et al., 2004).

The mismatch is predictable: someone is told “no jumping right now” (pelvic floor symptom provocation, joint flare, bone stress history, or impact aversion after setbacks), while many “bone workouts” default to hops and bounds. If impact isn’t tolerable today, a structured bridge helps prevent the common swing between **under-dosing** (lots of comfortable movement that doesn’t challenge bone-relevant variables) and **flare-ups** (too much, too soon).

This bridge targets three adaptation lanes that do not progress on identical timelines:

1) **Bone stimulus variables:** prioritize **magnitude**, **rate** *(how fast force is applied)*, and **distribution/novelty** of loading (Turner, 1998). Bone also shows a **saturation/refractory** effect *(it stops “counting” endless identical reps after a small number of high-quality hits)*, so a small number of well-chosen loading cycles can matter more than endless reps (Robling et al., 2001; Robling, Burr & Turner, 2006).

2) **Tendon + foot/ankle capacity:** build tolerance for faster forces with staged progressions: start with **isometrics or heavy-slow calf raises 2–3×/week**, then progress to **faster, shorter-contact calf work** only when next-day stiffness and symptom response stay stable (Cook & Purdam; Malliaras/van Ark frameworks).

3) **Optional future landing skill:** landing mechanics can be trained later, once tissues tolerate faster forces.

## Two Predictable Failure Modes (and why they happen)

### 1) Under-dose: “hard work” that still under-loads bone
Bone is selective about stimulus. Across models of bone adaptation, **strain magnitude** *(how much bone is deformed)*, **strain rate** *(how fast that deformation happens)*, and **distribution/novelty** tend to matter more than simply doing more cycles (Turner, 1998). This helps explain why long walks, steady cardio, or moderate lifting can feel hard yet produce little hip/spine DXA change: metabolic stress is not the same as high bone strain. Adding more minutes can also run into diminishing returns because of saturation (Robling et al., 2001; Robling et al., 2006).

### 2) Too-early impact: chasing rate stimulus under fatigue
A common script is heavy-ish lifting followed by an impact “finisher” (burpees, box jumps). Power work is fatigue-sensitive; as velocity drops, the session shifts from “rate stimulus” into low-quality contacts (González-Badillo & Sánchez-Medina, 2010; Pareja-Blanco et al., 2017). That’s when tendon flare-ups, shin irritation, or pelvic floor symptom spikes become more likely—not because impact is inherently “bad,” but because **quality** has fallen while forces are still high-rate.

A practical guardrail is the **24-hour response check**: some discomfort during loading may be acceptable, but symptoms should return to baseline by the next day. Escalation or lingering suggests dose exceeded current capacity (Silbernagel heuristic).

## What this bridge is (and isn’t)

The goal is the “missing middle”: **anchor magnitude** with heavy strength training, add **fast concentric intent** to train part of rate without airtime, and broaden **distribution/novelty** via unilateral work and carries.

Scope note: this is written for **postmenopausal and late-perimenopausal** people where bone-density priorities are front and center. **Postpartum pelvic-floor rehab**, acute or suspected **stress injury**, and other situations requiring medical or pelvic health clearance need individualized guidance.

Evidence boundary: this is **not a replacement for impact** if maximizing BMD is the goal and impact becomes tolerable. Heavy resistance training plus impact remains the most reliable route (Watson et al., 2018). It’s a way to keep progressing key “bone dials” while building the capacity that makes later impact more predictable.

## Four Training Dials (with evidence tiers)

### Dial 1 — Magnitude (**gold standard**)
Trials like LIFTMOR and related heavy-loading work share a basic theme: **repeatable overload for months** (Watson et al., 2018). Practically, pick a small cluster of hip/spine-loading patterns (squat pattern, hinge pattern, one unilateral pattern) and get measurably stronger.

If symptoms constrain range or positions, keep the loading intent while changing the lift setup (e.g., box squat or belt squat instead of deep back squat; trap-bar deadlift instead of straight-bar). For pelvic floor tracking, validated tools like **ICIQ-UI SF** and **PFDI-20 subscales** can help detect patterns over time. They do **not** provide universal “clearance” thresholds (ICIQ-UI SF; PFDI-20).

Time horizons matter: DXA-detectable BMD change commonly needs **~6–12+ months**, and interpretation depends on **least significant change (LSC)**. If you use DXA to judge progress, ask the imaging center (or the report/radiology department) for **their facility’s LSC** for the hip/spine so you know what change is large enough to be considered “real” beyond measurement noise. Use interim markers too: repeatable load/rep progressions plus stable **24-hour** symptom response.

### Dial 2 — Rate via fast-intent strength (**function: gold standard; BMD: promising/variable**)
**High-velocity resistance training (HVRT)**—controlled eccentric, then “accelerate up” concentrically—reliably improves **muscle power and functional performance** in older-adult and postmenopausal trials, commonly run for **~8–16+ weeks** at **2–3 sessions/week** (e.g., Stengel; Fielding; Miszko; Henwood & Taaffe). Bone outcomes without impact are more variable, so label BMD effects as **promising/uncertain**.

To preserve the “rate” stimulus, manage fatigue (the rationale is simple: if reps slow down, you’re no longer training speed/power in the same way): low reps, longer rests, and stop when reps slow. Peak power commonly occurs around **~30–60% 1RM** in many lifts (exercise-dependent) (Kaneko et al., 1983; Cormie et al., 2011; Haff & Nimphius, 2012). One workable starting template is **5×3** with **2–3 min** rest, done early, then adjusted based on your next-day response and rep quality.

Quality rule (device-free): **end the set when reps become visibly slower or “grindy.”** If using velocity tools, smaller velocity loss (often **≤10–20%**) better preserves power quality than higher loss (González-Badillo & Sánchez-Medina, 2010; Pareja-Blanco et al., 2017).

### Dial 3 — Distribution (**mechanism: strong; dosing: uncertain**)
Bone also responds to where and in what direction strain occurs (Frost/Turner; Nikander reviews). Without jumping, this can be trained with unilateral patterns, offset loading, and frontal-plane work (e.g., lateral lunge) plus carries. Exact dosing in humans is not nailed down.

### Dial 4 — Novelty (**mechanism: strong; dosing: uncertain**)
Because of saturation/refractory effects, high-quality exposures matter more than endless fatigued reps (Robling et al., 2001; Robling et al., 2006). Avoid constant program churn that prevents progressive overload.

Practical rotation rule: keep main lifts stable **~4–8 weeks**, then change one variable (stance, implement, ROM, load placement) if progress stalls or symptoms require it. RCTs do not define a single “best” rotation cadence.

## The No-Impact Osteogenic Stack: 3-Part Weekly Template

### A) Heavy lower-body strength (**gold standard**)
Minimum-effective structure: **2 lower-body sessions/week**, anchored by one hinge, one squat pattern, and one unilateral lift. Better outcomes cluster around **~70–85% 1RM** over **6–12+ months** (Kohrt et al., 2004; Watson et al., 2018). Work mostly in **5–8 reps**, stopping **1–3 reps in reserve** to keep mechanics repeatable.

Modify vs stop: modify for mild, reversible symptom bumps; stop and seek evaluation for red flags such as **focal bone pain**, night pain, escalating pain with walking or hopping, or known high-risk stress injury sites (risk-stratified BSI guidance).

### B) Fast-intent strength (**function: gold; BMD: promising/variable**)
Add **3–6 sets of 3–6 reps**, **2–3 min** rest, early in the session. If breathing or metabolic burn becomes the limiter, the session has drifted away from power training. Cluster sets can help maintain output (Tufano et al., 2017).

### C) Carries + fast grounded contacts (**adjunct; direct BMD trials limited**)
Carries add loaded gait, trunk control, and different loading distribution. Evidence for falls reduction supports strength and balance training broadly (Sherrington et al., 2019). **Carry-only DXA trials are scarce**, so frame carries as a mechanistically aligned adjunct.

Progress carries via **load, position, distance/time**, using posture as the gate (no obvious side-bend or rotation). Add low-amplitude fast contacts (fast marches, stomp steps) only if next-day response stays calm; treat this as an intermediate exposure before any optional impact.

#### Boxed example: using the 24-hour check to adjust one dial (pelvic-floor focused)
You add **fast marches** after your strength work on Tuesday. During the session you feel fine, but Wednesday you notice **pelvic-floor heaviness** that’s clearly above baseline and lingers.

Next week, keep **magnitude** the same (same main lifts, same loads/reps), keep **distribution** the same (don’t add new unilateral or offset variants), and adjust only the **rate exposure**: cut the fast grounded contacts by **50%** (or remove them entirely) and keep the fast-intent sets earlier in the workout with longer rests. Re-test with the same 24-hour rule. If heaviness returns to baseline next day, you’ve found a tolerable rate dose; if it doesn’t, you’ve learned that “rate” needs a slower ramp right now—without throwing out your heavy strength work.

## What to Track (and what research still can’t promise)

Minimal dashboard:
- **2–3 anchor lifts:** load/reps (magnitude)
- **Crisp-rep count** on fast-intent sets (or velocity consistency if available)
- **Carry dose:** load × distance/time, with posture standard
- **Symptom log tied to sessions**, plus **24-hour response** (pelvic floor: leakage, heaviness, bulge; tendon/joint pain and next-day stiffness). Tools like **ICIQ-UI SF** and **PFDI-20** can quantify trends but do not define universal “safe lifting” thresholds.

Limits to state clearly: HVRT improves power/function reliably, but BMD effects without impact are **smaller and less consistent** than heavy resistance training with (and sometimes without) impact. Carry-only BMD evidence is limited. And dosing questions in women’s health are still under-answered in parts of the literature. The practical response is **criteria-based progression**, changing **one dial at a time**, and letting tracked outcomes decide the next step.

Heavy progressive lifting over months is still the anchor. The bridge simply keeps you out of the under-dose/flare-up loop by giving you controllable levers—especially if impact is off the table right now.

Which dial—magnitude, rate, distribution, or novelty—would you adjust first, and what does your next-day response typically tell you?

**References (selected):** Watson et al., 2018; Kohrt et al., 2004; Turner, 1998; Robling et al., 2001; Robling, Burr & Turner, 2006; González-Badillo & Sánchez-Medina, 2010; Pareja-Blanco et al., 2017; Kaneko et al., 1983; Cormie et al., 2011; Haff & Nimphius, 2012; Tufano et al., 2017; Sherrington et al., 2019; ICIQ-UI SF; PFDI-20; Stengel/Fielding/Miszko/Henwood & Taaffe (HVRT trials).